Metacognitive Therapy of Early Traumatized Patients With Borderline Personality Disorder: A Phase-II Baseline Controlled Trial

التفاصيل البيبلوغرافية
العنوان: Metacognitive Therapy of Early Traumatized Patients With Borderline Personality Disorder: A Phase-II Baseline Controlled Trial
المؤلفون: Hans M. Nordahl, Adrian Wells
المصدر: Frontiers in Psychology, Vol 10 (2019)
Frontiers in Psychology
JULY
Nordahl, H M & Wells, A 2019, ' Metacognitive therapy of early traumatized patients with borderline personality disorder : A phase-II baseline-controlled trial ', Frontiers in Psychology, vol. 10, no. JULY, 1694 . https://doi.org/10.3389/fpsyg.2019.01694
بيانات النشر: Frontiers Media SA, 2019.
سنة النشر: 2019
مصطلحات موضوعية: medicine.medical_specialty, lcsh:BF1-990, Early childhood abuse, 050105 experimental psychology, law.invention, 03 medical and health sciences, Metacognitive therapy, 0302 clinical medicine, Randomized controlled trial, law, Rumination, early childhood abuse, medicine, Psychology, Outpatient clinic, 0501 psychology and cognitive sciences, Borderline personality disorder, General Psychology, Original Research, 05 social sciences, rumination, self-harming behavior, medicine.disease, metacognitive therapy, Personality disorders, Self-harming behavior, lcsh:Psychology, Mood, Physical abuse, Physical therapy, Anxiety, medicine.symptom, Borderline personality Disorder, 030217 neurology & neurosurgery, Metacognitive Therapy (MCT), borderline personality disorder
الوصف: Metacognitive therapy (MCT) is proving to be an effective and brief treatment for anxiety disorders and depression, but there are no investigations of its feasibility and effect on primary personality disorders. We conducted a baseline controlled phase II trial of MCT on a group of patients with Borderline personality disorder all reporting early trauma history with sexual or physical abuse. All had been referred to our study after hospitalization and subsequently treated at the university outpatient clinic at NTNU. Twelve patients referred for severe long-term trauma and emotional instability were offered participation in the program. All gave their consent and were included in the trial. We aimed to examine retention over treatment and follow-up, if the treatment can be delivered in a standardized way across complex and heterogeneous patients and any evidence associated with treatment effects on a range of measures to inform subsequent trials. We measured change in mood, borderline-related symptoms, interpersonal problems, trauma symptoms, suicidal thoughts and self-harming behaviors across pre- post-treatment and by 1- and 2-year follow-up. Treatment appeared feasible with all patients completing the course and 11 out of 12 completing all follow-up assessments. All outcome measures showed a high retention rate and no drop-outs from the treatment. Large improvements over time and treatment gains were maintained at 2 years. There was significant reduction of borderline symptom severity, interpersonal problems and trauma symptoms from pre to 2-year follow-up. The results indicate that MCT may be applied to Borderline personality disorder and that future more definitive trials are warranted. Copyright © 2019 Nordahl and Wells. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY).
تدمد: 1664-1078
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2648e5afa34268495a90181ece187c17
https://doi.org/10.3389/fpsyg.2019.01694
حقوق: OPEN
رقم الأكسشن: edsair.doi.dedup.....2648e5afa34268495a90181ece187c17
قاعدة البيانات: OpenAIRE